VIGAMOX Side Effects

6974623-X | Abortion Spontaneous
on Sep 09, 2010 Female patient from UNITED STATES , 32 years of age, weighting 126.0 lb, was diagnosed with conjunctivitis infective and was treated with Vigamox (View Usage). Patient experienced the following unwanted or unexpected effects: abortion spontaneous. Vigamox dosage: 1 Drop Each Eye 1 Daily Other. Patient was hospitalized.

6814551-3 | Eye Irritation, Eye Pain, Sensation Of Foreign Body, Visual Acuity Reduced
Patient was taking Vigamox (View Usage). Patient had the following side effects: eye irritation, eye pain, sensation of foreign body, visual acuity reduced on Mar 26, 2010 from UNITED STATES Additional patient health information: Female patient , weighting 156.0 lb, was diagnosed with prophylaxis and. Vigamox dosage: Tid Ophthalmic. During the same period patient was treated with NEVANAC (Tid Ophthalmic) (View Nevanac Review and Nevanac Label ), DIGOXIN (View Digoxin Review and Digoxin Label ).

6804457-8 | Eye Swelling, Ocular Hyperaemia, Pyrexia, Vomiting
Adverse event was reported on Jun 28, 2010 by a Female patient taking Vigamox (View Usage) (Dosage: One Drop 3x A Day Intraocular) was diagnosed with conjunctivitis infective and. Location: UNITED STATES , child 11 years of age, weighting 119.0 lb, After Vigamox was administered, patient had the following side effects: eye swelling, ocular hyperaemia, pyrexia, vomiting.

6798927-9 | Corneal Oedema, Visual Acuity Reduced
on Jun 12, 2010 Female patient from INDIA , 60 years of age, was treated with Vigamox (View Usage). Patient experienced the following unwanted or unexpected effects: corneal oedema, visual acuity reduced. Vigamox dosage: 0.1ml Via Intracameral Injection Intraocular. During the same period patient was treated with HYDROXYPROPYL METHYLCELLULOSE (HYPROMELLOSE) (View Hydroxypropyl Methylcellulose (hypromellose) Review and Hydroxypropyl Methylcellulose (hypromellose) Label ), XYLOCAINE (View Xylocaine Review and Xylocaine Label ).


6750400-X | Corneal Opacity, Keratopathy
on May 13, 2010 Female patient from UNITED STATES , weighting 130.0 lb, was diagnosed with photorefractive keratectomy and was treated with Vigamox (View Usage). Patient had the following side effects: corneal opacity, keratopathy. Vigamox dosage: 1 Gtt Qid Ophthalmic. During the same period patient was treated with ALCAINE (Ophthalmic) (View Alcaine Review and Alcaine Label ), OMNIPRED (Qid Until 13-apr-2010; Then Bid Until 17-apr-2010 Ophthalmic) (View Omnipred Review and Omnipred Label ), BSS (View Bss Review and Bss Label ), SYSTANE (View Systane Review and Systane Label ).

6730608-X | Keratopathy
Patient was taking Vigamox (View Usage). After Vigamox was administered, patient had the following side effects: keratopathy on Apr 29, 2010 from UNITED STATES Additional patient health information: Female patient , weighting 130.0 lb, was diagnosed with photorefractive keratectomy and. Vigamox dosage: 1 Gtt Qid Ophthalmic. During the same period patient was treated with ALCAINE (Ophthalmic) (View Alcaine Review and Alcaine Label ), OMNIPRED (Qid Until 13-apr-2010; Then Bid Until 17-apr-2010 Ophthalmic) (View Omnipred Review and Omnipred Label ), BSS (View Bss Review and Bss Label ), SYSTANE (View Systane Review and Systane Label ).

6693673-4 | Corneal Oedema, Visual Acuity Reduced
Adverse event was reported on Apr 05, 2010 by a Female patient taking Vigamox (View Usage) (Dosage: 0.1ml Bia Intracameral Injection, Intraocular) . Location: INDIA , 60 years of age, Patient experienced the following unwanted or unexpected effects: corneal oedema, visual acuity reduced. During the same period patient was treated with HYDROXYPROPYL METHYLCELLULOSE (HYPROMELLOSE) (View Hydroxypropyl Methylcellulose (hypromellose) Review and Hydroxypropyl Methylcellulose (hypromellose) Label ), XYLOCAINE (View Xylocaine Review and Xylocaine Label ).

6678861-5 | Diplopia, Vision Blurred
on Apr 12, 2010 Female patient from UNITED STATES , weighting 122.0 lb, was diagnosed with conjunctivitis and was treated with Vigamox (View Usage). Patient had the following side effects: diplopia, vision blurred. Vigamox dosage: 2 Drops Each Eye 4x/day Ophthalmic.

6666431-4 | Blepharitis, Eye Discharge, Eye Haemorrhage, Eye Infection, Eye Swelling, Ocular Hyperaemia
on Mar 22, 2010 Male patient from UNITED STATES , weighting 28.00 lb, was diagnosed with conjunctivitis and was treated with Vigamox (View Usage). After Vigamox was administered, patient had the following side effects: blepharitis, eye discharge, eye haemorrhage, eye infection (What is eye infection?), eye swelling, ocular hyperaemia. Vigamox dosage: One Gtt Ou Q 12 Hours Ophthalmic.

6662411-3 | Eye Irritation, Eye Pain, Visual Acuity Reduced
Patient was taking Vigamox (View Usage). Patient experienced the following unwanted or unexpected effects: eye irritation, eye pain, visual acuity reduced on Mar 11, 2010 from UNITED STATES Additional patient health information: Female patient , weighting 156.0 lb, was diagnosed with prophylaxis and. Vigamox dosage: (tid Ophthalmic). During the same period patient was treated with NEVANAC ((tid Opthalmic)) (View Nevanac Review and Nevanac Label ), DIGOXIN (View Digoxin Review and Digoxin Label ).

6654184-5 | Endophthalmitis, Eye Infection Staphylococcal, Pathogen Resistance
Adverse event was reported on Mar 11, 2010 by a Male patient taking Vigamox (View Usage) (Dosage: Qid - Q1h, Ophthalmic) was diagnosed with postoperative care and. Location: CANADA , 75 years of age, Patient had the following side effects: endophthalmitis, eye infection staphylococcal, pathogen resistance. Patient was hospitalized.

6649496-5 | Urticaria
on Mar 24, 2010 Female patient from UNITED STATES , weighting 25.00 lb, was diagnosed with conjunctivitis bacterial and was treated with Vigamox (View Usage). After Vigamox was administered, patient had the following side effects: urticaria. Vigamox dosage: 1-2 Drops Bid Ophthalmic. During the same period patient was treated with CEFDINIR (View Cefdinir Review and Cefdinir Label ).

6635884-X | Blister, Conjunctival Scar, Eye Haemorrhage, Eyelid Ptosis, Hypoaesthesia Facial, Ocular Hyperaemia, Photophobia
on Feb 25, 2010 Female patient from UNITED STATES , weighting 264.0 lb, was diagnosed with conjunctivitis infective and was treated with Vigamox (View Usage). Patient experienced the following unwanted or unexpected effects: blister, conjunctival scar, eye haemorrhage, eyelid ptosis, hypoaesthesia facial, ocular hyperaemia, photophobia. Vigamox dosage: One Gtt Tid Os Ophthalmic. During the same period patient was treated with SIMVASTATIN (View Simvastatin Review and Simvastatin Label ), MOBIC (View Mobic Review and Mobic Label ).

6619438-7 | Endophthalmitis, Staphylococcal Infection
Patient was taking Vigamox (View Usage). Patient had the following side effects: endophthalmitis, staphylococcal infection (What is staphylococcal infection?) on Feb 17, 2010 from CANADA Additional patient health information: Male patient , 75 years of age, was diagnosed with postoperative care and. Vigamox dosage: Qid-qih. Patient was hospitalized.

6523055-7 | Blood Pressure Increased, Retinal Haemorrhage, Tendonitis
Adverse event was reported on Dec 08, 2009 by a Female patient taking Vigamox (View Usage) (Dosage: See Image) was diagnosed with prophylaxis and. Location: UNITED STATES , 52 years of age, After Vigamox was administered, patient had the following side effects: blood pressure increased, retinal haemorrhage, tendonitis. During the same period patient was treated with CORTICOSTEROIDS (View Corticosteroids Review and Corticosteroids Label ), LISINOPRIL (View Lisinopril Review and Lisinopril Label ).

6433459-9 | Lacrimation Increased, Swelling
on Nov 06, 2009 Male patient from UNITED STATES , weighting 35.00 lb, was diagnosed with conjunctivitis and was treated with Vigamox (View Usage). Patient experienced the following unwanted or unexpected effects: lacrimation increased, swelling. Vigamox dosage: 1 Drop 3x Ophthalmic.

6361638-8 | Tendon Rupture
on Sep 15, 2009 Male patient from UNITED STATES , weighting 200.0 lb, was diagnosed with conjunctival abrasion and was treated with Vigamox (View Usage). Patient had the following side effects: tendon rupture. Vigamox dosage: One Drop Tid Ophthalmic. Patient was hospitalized.

6334859-8 | Epistaxis
Patient was taking Vigamox (View Usage). After Vigamox was administered, patient had the following side effects: epistaxis on Aug 21, 2009 from UNITED STATES Additional patient health information: Female patient , 32 years of age, weighting 170.0 lb, was diagnosed with eye inflammation, glaucoma (What is glaucoma?) and. Vigamox dosage: Ophthalmic. During the same period patient was treated with OMNIPRED (Ophthalmic) (View Omnipred Review and Omnipred Label ), AZOPT (1 Gtt In Od 1pm Ophthalmic, 1 Gtt In Ou Ophthalmic) (View Azopt Review and Azopt Label ), COSOPT (View Cosopt Review and Cosopt Label ), ALPHAGAN (View Alphagan Review and Alphagan Label ), PILOCARPINE HCL (View Pilocarpine Hcl Review and Pilocarpine Hcl Label ).

6248318-4 | Epistaxis
Adverse event was reported on Jun 10, 2009 by a Female patient taking Vigamox (View Usage) (Dosage: Ophthalmic) was diagnosed with eye inflammation, glaucoma (What is glaucoma?) and. Location: UNITED STATES , 33 years of age, Patient experienced the following unwanted or unexpected effects: epistaxis. During the same period patient was treated with OMNIPRED (Ophthalmic) (View Omnipred Review and Omnipred Label ), AZOPT (Ophthalmic) (View Azopt Review and Azopt Label ), COSPOT (View Cospot Review and Cospot Label ), ALPHAGAN (View Alphagan Review and Alphagan Label ), PILOCARPINE HCL (View Pilocarpine Hcl Review and Pilocarpine Hcl Label ).

6247209-2 | Erythema, Eye Swelling, Feeling Abnormal, Pruritus, Swelling Face, Urticaria
on Jun 24, 2009 Female patient from UNITED STATES , 66 years of age, weighting 119.0 lb, was diagnosed with cataract (What is cataract?) and was treated with Vigamox (View Usage). Patient had the following side effects: erythema, eye swelling, feeling abnormal, pruritus, swelling face, urticaria. Vigamox dosage: 1 Drop 4 Times Per Day Ophthalmic. During the same period patient was treated with NEVANAC (View Nevanac Review and Nevanac Label ).

6213782-3 | Epistaxis
on May 19, 2009 Female patient from UNITED STATES , 33 years of age, was diagnosed with eye inflammation, glaucoma (What is glaucoma?) and was treated with Vigamox (View Usage). After Vigamox was administered, patient had the following side effects: epistaxis. Vigamox dosage: (ophthalmic). During the same period patient was treated with OMNIPRED ((ophthalmic)) (View Omnipred Review and Omnipred Label ), AZOPT ((ophthalmic)) (View Azopt Review and Azopt Label ), COSOPT (View Cosopt Review and Cosopt Label ), PILOCARPINE HCL (View Pilocarpine Hcl Review and Pilocarpine Hcl Label ), ALPHAGAN (View Alphagan Review and Alphagan Label ).

6212599-3 | Heart Rate Increased
Patient was taking Vigamox (View Usage). Patient experienced the following unwanted or unexpected effects: heart rate increased on Jun 02, 2009 from UNITED STATES Additional patient health information: Female patient , 63 years of age, weighting 155.0 lb, was diagnosed with preoperative care and. Vigamox dosage: 1 Qtt Od X 2 Doses Right Eye.

6210296-1 | Ocular Hyperaemia, Rash
Adverse event was reported on May 29, 2009 by a Male patient taking Vigamox (View Usage) (Dosage: 1 Drop In Both Eyes 2x Daily Ophthalmic) was diagnosed with conjunctivitis infective, infection (What is infection?) and. Location: UNITED STATES , child 11 years of age, weighting 105.0 lb, Patient had the following side effects: ocular hyperaemia, rash (What is rash?).

6121060-6 | Anxiety, Arthralgia, Balance Disorder, Dizziness, Headache, Heart Rate Increased, Insomnia, Myalgia, Nausea
on Mar 12, 2009 Female patient from UNITED STATES , 69 years of age, weighting 115.0 lb, was diagnosed with cataract operation and was treated with Vigamox (View Usage). After Vigamox was administered, patient had the following side effects: anxiety (What is anxiety?), arthralgia, balance disorder, dizziness (What is dizziness?), headache (What is headache?), heart rate increased, insomnia, myalgia, nausea (What is nausea?). Vigamox dosage: 1 Drop Four Times A Day Ophthalmic. During the same period patient was treated with NEVANAC (View Nevanac Review and Nevanac Label ).

6101879-8 | Erythema, Exophthalmos, Pruritus, Skin Discolouration, Swelling Face
on Mar 03, 2009 Male patient from UNITED STATES , child 9 years of age, weighting 125.0 lb, was diagnosed with conjunctivitis infective and was treated with Vigamox (View Usage). Patient experienced the following unwanted or unexpected effects: erythema, exophthalmos, pruritus, skin discolouration, swelling face. Vigamox dosage: 1 Drop 3 X's Day Ophthalmic One Drop In Each Eye. During the same period patient was treated with VIGAAMOX (View Vigaamox Review and Vigaamox Label ).

6094112-7 | Abnormal Behaviour, Affect Lability, Crying, Dry Mouth, Fatigue, Feeling Abnormal, Inappropriate Affect, Initial Insomnia, Memory Impairment
Patient was taking Vigamox (View Usage). Patient had the following side effects: abnormal behaviour, affect lability, crying, dry mouth, fatigue, feeling abnormal, inappropriate affect, initial insomnia, memory impairment on Feb 24, 2009 from UNITED STATES Additional patient health information: Female patient , child 11 years of age, weighting 81.00 lb, was diagnosed with conjunctivitis and. Vigamox dosage: One Drop In Each Eye Three Times Daily Intraocular.

6089144-9 | Hypersensitivity
Adverse event was reported on Feb 20, 2009 by a Female patient taking Vigamox (View Usage) (Dosage: 3ml 1 Drop 2 Times Day Opthalmic, 1 Dose) was diagnosed with conjunctivitis bacterial and. Location: UNITED STATES , child 5. years of age, weighting 48.00 lb, After Vigamox was administered, patient had the following side effects: hypersensitivity.

5919685-3 | Anaphylactic Shock, Dizziness, Palpitations
on Oct 01, 2008 Female patient from JAPAN , 76 years of age, was diagnosed with prophylaxis and was treated with Vigamox (View Usage). Patient experienced the following unwanted or unexpected effects: anaphylactic shock, dizziness (What is dizziness?), palpitations. Vigamox dosage: 1 Gtt Ou Qid. During the same period patient was treated with RIZABEN (TRANILAST) (View Rizaben (tranilast) Review and Rizaben (tranilast) Label ), HYALEIN (HYALURONATE SODIUM) (View Hyalein (hyaluronate Sodium) Review and Hyalein (hyaluronate Sodium) Label ), XALATAN (View Xalatan Review and Xalatan Label ).

5901016-6 | Anaphylactic Shock, Palpitations, Vertigo
on Sep 11, 2008 Female patient from JAPAN , 76 years of age, was diagnosed with prophylaxis and was treated with Vigamox (View Usage). Patient had the following side effects: anaphylactic shock, palpitations, vertigo. Vigamox dosage: 1 Gtt Ou Qid Ophthalmic. During the same period patient was treated with RIZABEN (TRANILAST) (View Rizaben (tranilast) Review and Rizaben (tranilast) Label ), HYALEIN (HYALURONATE SODIUM) (View Hyalein (hyaluronate Sodium) Review and Hyalein (hyaluronate Sodium) Label ), XALATAN (View Xalatan Review and Xalatan Label ).

5892643-3 | Arthralgia, Bone Pain, Chest Pain, Dyspnoea, Myalgia, Pain In Extremity, Paraesthesia
Patient was taking Vigamox (View Usage). After Vigamox was administered, patient had the following side effects: arthralgia, bone pain, chest pain (What is chest pain?), dyspnoea, myalgia, pain in extremity, paraesthesia on Sep 19, 2008 from UNITED STATES Additional patient health information: Female patient , weighting 113.0 lb, was diagnosed with conjunctivitis bacterial and. Vigamox dosage: One Drop Tid Topical. During the same period patient was treated with FML EYE DROPS (View Fml Eye Drops Review and Fml Eye Drops Label ).

5841170-8 | Discomfort, Erythema, Influenza Like Illness, Musculoskeletal Stiffness, Rash, Swelling, Urticaria
Adverse event was reported on Aug 07, 2008 by a Female patient taking Vigamox (View Usage) (Dosage: 1 Drop 4 Times Da./7days Ophthalmic) was diagnosed with cataract operation and. Location: UNITED STATES , 80 years of age, weighting 122.0 lb, Patient experienced the following unwanted or unexpected effects: discomfort, erythema, influenza like illness, musculoskeletal stiffness, rash (What is rash?), swelling, urticaria.

5753797-2 | Cough, Dysphagia, Pharyngolaryngeal Pain, Pyrexia
on May 27, 2008 Female patient from UNITED STATES , 40 years of age, weighting 154.0 lb, was diagnosed with conjunctivitis infective and was treated with Vigamox (View Usage). Patient had the following side effects: cough, dysphagia, pharyngolaryngeal pain, pyrexia. Vigamox dosage: 1 Drop 3x Per Day Ophthalmic.

5622592-7 | Application Site Irritation
on Feb 11, 2008 Female patient from UNITED STATES , 19 years of age, was treated with Vigamox (View Usage). After Vigamox was administered, patient had the following side effects: application site irritation. Vigamox dosage: 3mls 1 Drop 3 Times/day Eye Drop.

5566692-9 | Photophobia, Ulcerative Keratitis
Patient was taking Vigamox (View Usage). Patient experienced the following unwanted or unexpected effects: photophobia, ulcerative keratitis on Dec 17, 2007 from UNITED STATES Additional patient health information: Male patient , 22 years of age, was diagnosed with corrective lens user and. Vigamox dosage: .

5543733-6 | Atrial Fibrillation, Blood Pressure Decreased, Treatment Noncompliance
Adverse event was reported on Nov 13, 2007 by a Male patient taking Vigamox (View Usage) (Dosage: (2 Gtt Q1h Ophthalmic)) was diagnosed with ulcerative keratitis and. Location: UNITED STATES , 49 years of age, weighting 230.0 lb, Patient had the following side effects: atrial fibrillation (What is atrial fibrillation?), blood pressure decreased, treatment noncompliance.

5531968-8 | Conjunctival Haemorrhage, Eye Discharge, Eyelid Oedema, Purulent Discharge, Skin Discolouration
on Nov 28, 2007 Female patient from UNITED STATES , child 3 years of age, weighting 43.00 lb, was diagnosed with conjunctivitis and was treated with Vigamox (View Usage). After Vigamox was administered, patient had the following side effects: conjunctival haemorrhage, eye discharge, eyelid oedema, purulent discharge, skin discolouration. Vigamox dosage: 1-2 Drops Twice A Day Ophthalmic (duration: 2 Doses). During the same period patient was treated with SINGULAIR (View Singulair Review and Singulair Label ), M.V.I. (View M.v.i. Review and M.v.i. Label ), PULMICORT (View Pulmicort Review and Pulmicort Label ).

5517719-1 | Atrial Fibrillation, Blood Pressure Decreased
on Oct 30, 2007 Male patient from UNITED STATES , 49 years of age, weighting 230.0 lb, was diagnosed with ulcerative keratitis and was treated with Vigamox (View Usage). Patient experienced the following unwanted or unexpected effects: atrial fibrillation (What is atrial fibrillation?), blood pressure decreased. Vigamox dosage: (2 Gtt Q1h Ophthalmic).

5470678-2 | Corneal Oedema, Intraocular Pressure Increased, Vision Blurred
Patient was taking Vigamox (View Usage). Patient had the following side effects: corneal oedema, intraocular pressure increased, vision blurred on Sep 10, 2007 from JAPAN Additional patient health information: Male patient , 85 years of age, was diagnosed with antibiotic prophylaxis and. Vigamox dosage: 1 Gtt Os Qid. During the same period patient was treated with BRONUCK (BROMFENAC SODIUM) (View Bronuck (bromfenac Sodium) Review and Bronuck (bromfenac Sodium) Label ), DIAGNOGREEN (INDOCYANINE GREEN) (View Diagnogreen (indocyanine Green) Review and Diagnogreen (indocyanine Green) Label ), DEXAMETHASONE SODIUM METASULFOBENZOATE (View Dexamethasone Sodium Metasulfobenzoate Review and Dexamethasone Sodium Metasulfobenzoate Label ), PHENYLEPHRINE W/TROPICAMIDE (FOTORRETIN) (View Phenylephrine W/tropicamide (fotorretin) Review and Phenylephrine W/tropicamide (fotorretin) Label ), AMPICILLIN SODIUM W/SULBACTAM SODIUM (UNACID) (View Ampicillin Sodium W/sulbactam Sodium (unacid) Review and Ampicillin Sodium W/sulbactam Sodium (unacid) Label ), HYALURONATE SODIUM (View Hyaluronate Sodium Review and Hyaluronate Sodium Label ), BSS PLUS (View Bss Plus Review and Bss Plus Label ), PILOCARPINE HYDROCHLORIDE (View Pilocarpine Hydrochloride Review and Pilocarpine Hydrochloride Label ). Patient was hospitalized.

5406247-X | Tendonitis
Adverse event was reported on Aug 02, 2007 by a Male patient taking Vigamox (View Usage) (Dosage: One Drop 4 Times Daily Intraocular) was diagnosed with cataract operation and. Location: UNITED STATES , 77 years of age, weighting 175.0 lb, After Vigamox was administered, patient had the following side effects: tendonitis.

5286035-8 | Condition Aggravated, Eye Pain, Ulcerative Keratitis, Visual Acuity Reduced
on Mar 15, 2007 Male patient from UNITED STATES , 84 years of age, was diagnosed with ulcerative keratitis and was treated with Vigamox (View Usage). Patient experienced the following unwanted or unexpected effects: condition aggravated, eye pain, ulcerative keratitis, visual acuity reduced. Vigamox dosage: 1 Gtt Os Tid - Qid X 5 Weeks Ophthalmic.

5286031-0 | Conjunctival Hyperaemia, Corneal Disorder, Corneal Oedema, Corneal Scar, Hypopyon, Ocular Toxicity, Ulcerative Keratitis, Visual Acuity Reduced
on Mar 15, 2007 Female patient from UNITED STATES , 41 years of age, was diagnosed with keratitis bacterial and was treated with Vigamox (View Usage). Patient had the following side effects: conjunctival hyperaemia, corneal disorder, corneal oedema, corneal scar, hypopyon, ocular toxicity, ulcerative keratitis, visual acuity reduced. Vigamox dosage: 1 Gtt Os Q 2 Hours X 4 Weeks Ophthalmic. During the same period patient was treated with FML FORTE (View Fml Forte Review and Fml Forte Label ), ERYTHROMYCIN (View Erythromycin Review and Erythromycin Label ).

5245628-4 | Ruptured Cerebral Aneurysm
Patient was taking Vigamox (View Usage). After Vigamox was administered, patient had the following side effects: ruptured cerebral aneurysm on Feb 01, 2007 from UNITED STATES Additional patient health information: Male patient , 84 years of age, was diagnosed with prophylaxis and. Vigamox dosage: (ophthalmic). During the same period patient was treated with BSS (View Bss Review and Bss Label ).

5155459-1 | Carotid Artery Atheroma, Optic Ischaemic Neuropathy, Retinal Artery Occlusion
Adverse event was reported on Oct 24, 2006 by a Male patient taking Vigamox (View Usage) (Dosage: ) was diagnosed with prophylaxis and. Location: UNITED STATES , 75 years of age, weighting 175.0 lb, Patient experienced the following unwanted or unexpected effects: carotid artery atheroma, optic ischaemic neuropathy, retinal artery occlusion. During the same period patient was treated with ECONOPRED PLUS (1 Gtt Qid Opht) (View Econopred Plus Review and Econopred Plus Label ), MINITRAN (View Minitran Review and Minitran Label ), LISINOPRIL (View Lisinopril Review and Lisinopril Label ), TOPROL XL (View Toprol-xl Review and Toprol-xl Label ), FERGON (View Fergon Review and Fergon Label ).

5017912-0 | Dysphagia, Ear Disorder, Pain, Pyrexia, Rash, Vomiting
on Jun 02, 2006 Male patient from UNITED STATES , weighting 25.00 lb, was diagnosed with eye infection (What is eye infection?) and was treated with Vigamox (View Usage). Patient had the following side effects: dysphagia, ear disorder, pain (What is pain?), pyrexia, rash (What is rash?), vomiting. Vigamox dosage: .

4975062-3 | Conjunctival Haemorrhage
on Apr 14, 2006 Female patient from UNITED STATES , child 4 years of age, weighting 45.00 lb, was diagnosed with conjunctivitis bacterial and was treated with Vigamox (View Usage). After Vigamox was administered, patient had the following side effects: conjunctival haemorrhage. Vigamox dosage: 1 Drop Tid Otic.

4971637-6 | Ulcerative Keratitis, Visual Acuity Reduced
Patient was taking Vigamox (View Usage). Patient experienced the following unwanted or unexpected effects: ulcerative keratitis, visual acuity reduced on Mar 22, 2006 from UNITED STATES Additional patient health information: Male patient , 33 years of age, was diagnosed with prophylaxis and. Vigamox dosage: 2 Gtt Tid Opht. During the same period patient was treated with ACULAR (2 Gtt Qid Opht) (View Acular Review and Acular Label ).

4945306-2 | Acanthamoeba Infection, Keratitis, Keratitis Fungal
Adverse event was reported on Mar 15, 2006 by a Male patient taking Vigamox (View Usage) (Dosage: 1gtt Os Q2h X 1 Day Around The Clock) was diagnosed with keratitis and. Location: UNITED STATES , 23 years of age, Patient had the following side effects: acanthamoeba infection, keratitis, keratitis fungal.

4941415-2 | Acanthamoeba Infection, Keratitis, Keratitis Fungal
on Mar 10, 2006 Male patient from UNITED STATES , 23 years of age, was diagnosed with keratitis and was treated with Vigamox (View Usage). After Vigamox was administered, patient had the following side effects: acanthamoeba infection, keratitis, keratitis fungal. Vigamox dosage: 1 Gtt 05 Q2h X 1 Day Around The Clock.

4939246-2 | Corneal Transplant, Keratitis Fungal
on Mar 09, 2006 Male patient from UNITED STATES , 54 years of age, was diagnosed with keratitis fungal and was treated with Vigamox (View Usage). Patient experienced the following unwanted or unexpected effects: corneal transplant, keratitis fungal. Vigamox dosage: 1 Gtt Q2h X 48h Then Q3h X 3 Days Then Qid.

4937732-2 | Allergic Keratitis, Eye Infection Staphylococcal
Patient was taking Vigamox (View Usage). Patient had the following side effects: allergic keratitis, eye infection staphylococcal on Mar 08, 2006 from UNITED STATES Additional patient health information: Female patient , 42 years of age, was diagnosed with keratitis and. Vigamox dosage: Bid- Os Then Qid.